Hazlett, Burt & Watson’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20K Buy
837
+7
+0.8% +$170 0.01% 587
2025
Q4
$20K Buy
830
+11
+1% +$267 0.01% 596
2025
Q3
$20K Buy
+819
New +$19.9K 0.01% 562

Other funds holding IBDS

Hazlett, Burt & Watson's IBDS Position: Q1 2026 in Review

Hazlett, Burt & Watson increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 0.84% in Q1 2026, buying an estimated $170 and bringing the position to 837 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #587.

Hazlett, Burt & Watson first reported a position in IBDS in Q3 2025 and has held it in 3 quarters since. 428 funds tracked by Wall St. Rank hold IBDS as of Q1 2026.

  • Hazlett, Burt & Watson held 837 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $20K as of Q1 2026.
  • Hazlett, Burt & Watson bought 7 iShares iBonds Dec 2027 Term Corporate ETF shares in Q1 2026, an estimated $170.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.01% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #587 holding.
  • Hazlett, Burt & Watson first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2025 and has held it in 3 quarters since.
  • 428 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.